Companies: 10,795·Total market cap: $144.5T
PacificHealth Laboratories, Inc.

PacificHealth Laboratories, Inc.

PHLIOTCConsumer Defensive
$0.00
+$0.00(+9900.00%)
Market Cap$438307
P/E Ratio
52W High$0.0001
52W Low$0.000001
Overview

PacificHealth Laboratories, Inc. (PHLI) Revenue

Annual & quarterly revenue history · segment & region breakdown

PHLI · revenue · updated Jun 9, 2026

Core revenue metrics

PacificHealth Laboratories, Inc. trailing twelve-month (TTM) revenue is $0.01B, a decrease of 3.97% year-over-year from $0.01B in FY2011.

TTM revenue
$0.01B
4-quarter sum · USD
YoY growth
-3.97%
vs FY2011 $0.01B
Price / sales
0.07×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$833K
8 employees
FY2011
$0.01B
FY2010
$0.01B
5Y CAGR
+-1.4%
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · PacificHealth Laboratories, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

20111996 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2011-12-31$0.01B-$0.00B-3.97%
2010-12-31$0.01B-$0.00B-9.93%
2009-12-31$0.01B+$0.00B+10.49%
2008-12-31$0.01B-$0.00B-2.58%
2007-12-31$0.01B+$0.00B+19.61%
2006-12-31$0.01B+$0.00B+14.06%
2005-12-31$0.01B-$0.00B-20.02%
2004-12-31$0.01B+$0.00B+24.82%
2003-12-31$0.01B+$0.00B+6.51%
2002-12-31$0.01B-$0.00B-16.68%
PHLI revenue by year · PHLI revenue history · PHLI annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income PacificHealth Laboratories, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

PacificHealth Laboratories, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from PacificHealth Laboratories, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

PHLI revenue · 4 questions

PHLI's trailing twelve-month (TTM) revenue is $0.01B. That is a decrease of 3.97% year-over-year from $0.01B in FY2011.

PHLI revenuePHLI annual revenuewhat is PHLI revenuePHLI TTM revenue

Source: FMP · PacificHealth Laboratories, Inc. SEC filings · GAAP · PacificHealth Laboratories, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026